Overview consensus statement

Peter R. Carroll; Philip W. Kantoff; Steven P. Balk; Myles A. Brown; Anthony V. D'amico; Daniel J. George; Gary D. Grossfeld; Candace S. Johnson; William Kevin Kelly; Laurence Klotz; W. Robert Lee; Deborah P. Lubeck; David G. Mcleod; William K. Oh; Alan Pollack; Oliver Sartor; Matthew R. Smith; Carol Hart

doi:10.1016/S0090-4295(02)01559-5

Overview consensus statement

Peter R. Carroll, Philip W. Kantoff, Steven P. Balk, Myles A. Brown, Anthony V. D'amico, Daniel J. George, Gary D. Grossfeld, Candace S. Johnson, William Kevin Kelly, Laurence Klotz, W. Robert Lee, Deborah P. Lubeck, David G. Mcleod, William K. Oh, Alan Pollack, Oliver Sartor, Matthew R. Smith, Carol Hart

Research output: Contribution to journal › Article › peer-review

26 Scopus citations

Original language	English
Pages (from-to)	1-6
Number of pages	6
Journal	Urology
Volume	60
Issue number	3 SUPPL. 1
DOIs	https://doi.org/10.1016/S0090-4295(02)01559-5
State	Published - Sep 2002
Externally published	Yes

Access to Document

10.1016/S0090-4295(02)01559-5

Cite this

@article{385a44fd34e7499bb8f981cfc9e34efe,

title = "Overview consensus statement",

author = "Carroll, {Peter R.} and Kantoff, {Philip W.} and Balk, {Steven P.} and Brown, {Myles A.} and D'amico, {Anthony V.} and George, {Daniel J.} and Grossfeld, {Gary D.} and Johnson, {Candace S.} and Kelly, {William Kevin} and Laurence Klotz and Lee, {W. Robert} and Lubeck, {Deborah P.} and Mcleod, {David G.} and Oh, {William K.} and Alan Pollack and Oliver Sartor and Smith, {Matthew R.} and Carol Hart",

note = "Funding Information: This supplement and conference were funded by an unrestricted educational grant from AstraZeneca Pharmaceuticals. Myles A. Brown is a paid consultant to, and is a study investigator funded by, Novartis Pharmaceuticals. Daniel J. George is a paid consultant to and a member of the speakers{\textquoteright} bureau for Novartis Pharmaceuticals; a paid consultant to TAP Pharmaceuticals; holds stock in and is on the editorial staff for Veritas Medicine; and is a study investigator funded by Wyeth-Ayerst. William Kevin Kelly is a member of the medical advisory board for Amgen Pharmaceuticals and a member of the speakers{\textquoteright} bureau for AstraZeneca Pharmaceuticals and Bristol-Meyers Squibb. Laurence Klotz is a member of the speakers{\textquoteright} bureau for and a paid consultant to AstraZeneca Pharmaceuticals; a paid consultant to Aventis Pharmaceuticals; and a study investigator funded by Abbott Laboratories Canada. W. Robert Lee is a member of the medical advisory board for Nycomed-Amersham. Deborah P. Lubeck is a study investigator funded by TAP Pharmaceuticals. David G. McLeod is a study investigator funded by AstraZeneca Pharmaceuticals. Alan Pollack is a paid consultant to Amgen Pharmaceuticals, AstraZeneca Pharmaceuticals, and TAP Pharmaceuticals. Oliver Sartor is a paid consultant to and a member of the medical advisory board for Atrix Pharmaceuticals. Matthew R. Smith is a study investigator funded by AstraZeneca Pharmaceuticals and is a paid consultant to and a study investigator funded by Novartis Pharmaceuticals. ",

year = "2002",

month = sep,

doi = "10.1016/S0090-4295(02)01559-5",

language = "English",

volume = "60",

pages = "1--6",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "3 SUPPL. 1",

}

TY - JOUR

T1 - Overview consensus statement

AU - Carroll, Peter R.

AU - Kantoff, Philip W.

AU - Balk, Steven P.

AU - Brown, Myles A.

AU - D'amico, Anthony V.

AU - George, Daniel J.

AU - Grossfeld, Gary D.

AU - Johnson, Candace S.

AU - Kelly, William Kevin

AU - Klotz, Laurence

AU - Lee, W. Robert

AU - Lubeck, Deborah P.

AU - Mcleod, David G.

AU - Oh, William K.

AU - Pollack, Alan

AU - Sartor, Oliver

AU - Smith, Matthew R.

AU - Hart, Carol

N1 - Funding Information: This supplement and conference were funded by an unrestricted educational grant from AstraZeneca Pharmaceuticals. Myles A. Brown is a paid consultant to, and is a study investigator funded by, Novartis Pharmaceuticals. Daniel J. George is a paid consultant to and a member of the speakers’ bureau for Novartis Pharmaceuticals; a paid consultant to TAP Pharmaceuticals; holds stock in and is on the editorial staff for Veritas Medicine; and is a study investigator funded by Wyeth-Ayerst. William Kevin Kelly is a member of the medical advisory board for Amgen Pharmaceuticals and a member of the speakers’ bureau for AstraZeneca Pharmaceuticals and Bristol-Meyers Squibb. Laurence Klotz is a member of the speakers’ bureau for and a paid consultant to AstraZeneca Pharmaceuticals; a paid consultant to Aventis Pharmaceuticals; and a study investigator funded by Abbott Laboratories Canada. W. Robert Lee is a member of the medical advisory board for Nycomed-Amersham. Deborah P. Lubeck is a study investigator funded by TAP Pharmaceuticals. David G. McLeod is a study investigator funded by AstraZeneca Pharmaceuticals. Alan Pollack is a paid consultant to Amgen Pharmaceuticals, AstraZeneca Pharmaceuticals, and TAP Pharmaceuticals. Oliver Sartor is a paid consultant to and a member of the medical advisory board for Atrix Pharmaceuticals. Matthew R. Smith is a study investigator funded by AstraZeneca Pharmaceuticals and is a paid consultant to and a study investigator funded by Novartis Pharmaceuticals.

PY - 2002/9

Y1 - 2002/9

UR - http://www.scopus.com/inward/record.url?scp=18644371958&partnerID=8YFLogxK

U2 - 10.1016/S0090-4295(02)01559-5

DO - 10.1016/S0090-4295(02)01559-5

M3 - Article

C2 - 12231036

AN - SCOPUS:18644371958

SN - 0090-4295

VL - 60

SP - 1

EP - 6

JO - Urology

JF - Urology

IS - 3 SUPPL. 1

ER -